Institute of Medicine's Landmark Report on Sharing Clinical Trial Data

In January this year, the Institute of Medicine in the U.S. released a landmark report on sharing clinical trail data. 

"Although clinical trials generate vast amounts of data, a large por­tion is never published or made available to other researchers. Data sharing could advance scientific discovery and improve clinical care by maximizing the knowl­edge gained from data collected in trials, stimulating new ideas for research, and avoiding unnecessarily duplicative trials. In response to 23 public- and private-sector sponsors in the United States and abroad, the Institute of Medicine (IOM) assembled a committee to develop guiding principles and a practical framework for the responsible sharing of clinical trial data. In its report, Sharing Clinical Trial Data: Maxi­mizing Benefits, Minimizing Risk, the committee concludes that sharing data is in the public interest, but a multi-stakeholder effort is needed to develop a culture, infrastructure, and policies that will foster responsible sharing—now and in the future."

http://iom.nationalacademies.org/Reports/2015/Sharing-Clinical-Trial-Data.aspx
 

Although clinical trials generate vast amounts of data, a large por­tion is never published or made available to other researchers. Data sharing could advance scientific discovery and improve clinical care by maximizing the knowl­edge gained from data collected in trials, stimulating new ideas for research, and avoiding unnecessarily duplicative trials. In response to 23 public- and private-sector sponsors in the United States and abroad, the Institute of Medicine (IOM) assembled a committee to develop guiding principles and a practical framework for the responsible sharing of clinical trial data. In its report, Sharing Clinical Trial Data: Maxi­mizing Benefits, Minimizing Risk, the committee concludes that sharing data is in the public interest, but a multi-stakeholder effort is needed to develop a culture, infrastructure, and policies that will foster responsible sharing—now and in the future. - See more at: http://iom.nationalacademies.org/Reports/2015/Sharing-Clinical-Trial-Data.aspx#sthash.5nFatiOk.dpuf

Although clinical trials generate vast amounts of data, a large por­tion is never published or made available to other researchers. Data sharing could advance scientific discovery and improve clinical care by maximizing the knowl­edge gained from data collected in trials, stimulating new ideas for research, and avoiding unnecessarily duplicative trials. In response to 23 public- and private-sector sponsors in the United States and abroad, the Institute of Medicine (IOM) assembled a committee to develop guiding principles and a practical framework for the responsible sharing of clinical trial data. In its report, Sharing Clinical Trial Data: Maxi­mizing Benefits, Minimizing Risk, the committee concludes that sharing data is in the public interest, but a multi-stakeholder effort is needed to develop a culture, infrastructure, and policies that will foster responsible sharing—now and in the future. - See more at: http://iom.nationalacademies.org/Reports/2015/Sharing-Clinical-Trial-Data.aspx#sthash.5nFatiOk.dpuf

Although clinical trials generate vast amounts of data, a large por­tion is never published or made available to other researchers. Data sharing could advance scientific discovery and improve clinical care by maximizing the knowl­edge gained from data collected in trials, stimulating new ideas for research, and avoiding unnecessarily duplicative trials. In response to 23 public- and private-sector sponsors in the United States and abroad, the Institute of Medicine (IOM) assembled a committee to develop guiding principles and a practical framework for the responsible sharing of clinical trial data. In its report, Sharing Clinical Trial Data: Maxi­mizing Benefits, Minimizing Risk, the committee concludes that sharing data is in the public interest, but a multi-stakeholder effort is needed to develop a culture, infrastructure, and policies that will foster responsible sharing—now and in the future. - See more at: http://iom.nationalacademies.org/Reports/2015/Sharing-Clinical-Trial-Data.aspx#sthash.5nFatiOk.dpuf

Although clinical trials generate vast amounts of data, a large por­tion is never published or made available to other researchers. Data sharing could advance scientific discovery and improve clinical care by maximizing the knowl­edge gained from data collected in trials, stimulating new ideas for research, and avoiding unnecessarily duplicative trials. In response to 23 public- and private-sector sponsors in the United States and abroad, the Institute of Medicine (IOM) assembled a committee to develop guiding principles and a practical framework for the responsible sharing of clinical trial data. In its report, Sharing Clinical Trial Data: Maxi­mizing Benefits, Minimizing Risk, the committee concludes that sharing data is in the public interest, but a multi-stakeholder effort is needed to develop a culture, infrastructure, and policies that will foster responsible sharing—now and in the future. - See more at: http://iom.nationalacademies.org/Reports/2015/Sharing-Clinical-Trial-Data.aspx#sthash.5nFatiOk.dpuf

Although clinical trials generate vast amounts of data, a large por­tion is never published or made available to other researchers. Data sharing could advance scientific discovery and improve clinical care by maximizing the knowl­edge gained from data collected in trials, stimulating new ideas for research, and avoiding unnecessarily duplicative trials. In response to 23 public- and private-sector sponsors in the United States and abroad, the Institute of Medicine (IOM) assembled a committee to develop guiding principles and a practical framework for the responsible sharing of clinical trial data. In its report, Sharing Clinical Trial Data: Maxi­mizing Benefits, Minimizing Risk, the committee concludes that sharing data is in the public interest, but a multi-stakeholder effort is needed to develop a culture, infrastructure, and policies that will foster responsible sharing—now and in the future. - See more at: http://iom.nationalacademies.org/Reports/2015/Sharing-Clinical-Trial-Data.aspx#sthash.5nFatiOk.dpuf